RNA oxidation in Alzheimer disease and related neurodegenerative disorders
The DOI matches its Crossref record; 137 of the 138 references it cites were found in a registry or an index.
Abstract
RNA oxidation and its biological effects are less well studied compared to DNA oxidation. However, RNA may be more susceptible to oxidative insults than DNA, for RNA is largely single-stranded and its bases are not protected by hydrogen bonding and less protected by specific proteins. Also, cellular RNA locates in the vicinity of mitochondria, the primary source of reactive oxygen species. Oxidative modification can occur not only in protein-coding RNAs, but also in non-coding RNAs that have been recently revealed to contribute towards the complexity of the mammalian brain. Damage to coding and non-coding RNAs will cause errors in proteins and disturbances in the regulation of gene expression. While less lethal than mutations in the genome and not inheritable, such sublethal damage to cells might be associated with underlying mechanisms of degeneration, especially age-associated neurodegeneration that is commonly found in the elderly population. Indeed, oxidative RNA damage has been described recently in most of the common neurodegenerative disorders including Alzheimer disease, Parkinson disease, dementia with Lewy bodies and amyotrophic lateral sclerosis. Of particular interest, the accumulating evidence obtained from studies on either human samples or experimental models coincidentally suggests that oxidative RNA damage is a feature in vulnerable neurons at early-stage of these neurodegenerative disorders, indicating that RNA oxidation actively contributes to the onset or…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as is oxidative damage to RNA29,30.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [30]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“A strong genetic link between oxidative damage and neurodegeneration has been suggested by the finding that in about 20% of patients with familial ALS, it is caused by a mutation in SOD1, a metalloenzyme that catalyzes the dismutation of the toxic superoxide (O2 ) to hydrogen peroxide (H2O2) [98].”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 4×
“bodies in PD) that form hallmark pathologies in the affected brains [66, 123].”
BackgroundInfluentialMotor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 3×
“Many lines of evidence have indicated that oxidative damage is involved in the pathogenesis of neurodegenerative disorders including AD, PD and ALS [5, 6, 8, 51, 55, 66, 82, 102].”
BackgroundReactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 4×
“mation that the oxidized RNAs were localized predominantly in the neuronal cells compared with glial cells [83, 84, 86–88, 135].”
BackgroundResultInfluentialSelf-citationOxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869 · cited 4×
“Many lines of evidence have indicated that oxidative damage is involved in the pathogenesis of neurodegenerative disorders including AD, PD and ALS [5, 6, 8, 51, 55, 66, 82, 102].”
BackgroundInfluential
Cited by
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Estrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
“Further, post-mortem analysis of brains from Alzheimer’s patients show markers of increased oxidative stress, including lipid peroxides, 8-oxoguanine, and oxidized amino acids (Gibson and Shi, 2010; Nunomura et al., 2009; Reddy, 2006).”
Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/ RNS generation
Ahmad, W., Ijaz, B., Shabbiri, K., Ahmed, F., & Rehman, S. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0379-z · Cited by 330
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration
Rao, V. K., Carlson, E. A., & Yan, S. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.003 · Cited by 324
Recent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274
“…imbalance is met by a series of complex reactions (mitochondrial dysfunction, impaired synaptic transmission, disruption of membrane integrity, impaired axonal transport, etc.) to establish a disease-related homeostasis balance (Crouch et al. 2008; Huber et al. 2007; Nunomura et al. 2006, 2009).”
BackgroundInfluentialViolet, M., Delattre, L., Tardivel, M., Sultan, A., Chauderlier, A., Caillierez, R., Talahari, S., Nesslany, F., Lefebvre, B., Bonnefoy, E., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00084 · Cited by 251
Does Alzheimer's disease begin in the brainstem?
Simic, G., Stanic, G., Mladinov, M., Jovanov‐Milosevic, N., Kostovic, I., & Hof, P. R. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01038.x · Cited by 204
Sestili, P., Martinelli, C., Colombo, E., Barbieri, E., Potenza, L., Sartini, S., & Fimognari, C. (2011) · Amino Acids · doi:10.1007/s00726-011-0875-5 · Cited by 200
Carvalho, C., & Moreira, P. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00806 · Cited by 177
Self-citationMyhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 152
Self-citationOxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
Che, Y., Wang, J.-F., Shao, L., & Young, L. T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090083 · Cited by 155
“9) [25–61] 45 (3.”
Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid
Yao, J., Irwin, R., Chen, S., Hamilton, R., Cadenas, E., & Brinton, R. D. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.001 · Cited by 132
Emerging connections between RNA and autophagy
Frankel, L. B., Lubas, M., & Lund, A. H. (2017) · Autophagy · doi:10.1080/15548627.2016.1222992 · Cited by 135
Nunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W., Tabaton, M., Lee, H.-G., Smith, M. A., Perry, G., & Zhu, X. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318248e614 · Cited by 130
Self-citationYao, J., Rettberg, J. R., Klosinski, L. P., Cadenas, E., & Brinton, R. D. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.005 · Cited by 123
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Li, Y.-B., Fu, Q., Guo, M., Du, Y., Chen, Y., & Cheng, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03075-8 · Cited by 113
Alzheimer's disease: Effects of β-amyloid on mitochondria
Tillement, L., Lecanu, L., & Papadopoulos, V. (2011) · Mitochondrion · doi:10.1016/j.mito.2010.08.009 · Cited by 136
Bellaver, B., Souza, D. G., Souza, D. O., & Quincozes-Santos, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9880-8 · Cited by 135
Upcoming Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
Fagan, A. M., & Perrin, R. J. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.42 · Cited by 117
Redox Control in Mammalian Embryo Development
Ufer, C., Wang, C. C., Borchert, A., Heydeck, D., & Kühn, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3044 · Cited by 132
A ‘garbage can’ for ribosomes: how eukaryotes degrade their ribosomes
Lafontaine, D. L. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.12.006 · Cited by 127
Mayes, J., Tinker, C. L., Kolosov, O. V., Zhang, H., Tabner, B. J., & Allsop, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525212 · Cited by 124
RNA and Oxidative Stress in Alzheimer’s Disease: Focus on microRNAs
Nunomura, A., & Perry, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2638130 · Cited by 109
Self-citationCase, A. J., McGill, J. L., Tygrett, L. T., Shirasawa, T., Spitz, D. R., Waldschmidt, T. J., Legge, K. L., & Domann, F. E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.025 · Cited by 107
Characterization of RNA damage under oxidative stress in Escherichia coli
Liu, M., Gong, X., Alluri, R. K., Wu, J., Sablo, T., & Li, Z. (2012) · Biological Chemistry · doi:10.1515/hsz-2011-0247 · Cited by 114
Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress
Castellani, R. J., & Perry, G. L. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.09.009 · Cited by 113
Self-citationMechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0607-8 · Cited by 112
Pimentel, C., Batista-Nascimento, L., Rodrigues-Pousada, C., & Menezes, R. A. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/132146 · Cited by 85
Estrogen Regulation of Mitochondrial Bioenergetics
Yao, J., & Brinton, R. D. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00010-6 · Cited by 88
Gan, W., Nie, B., Shi, F., Xu, X., Qian, J., Takagi, Y., Hayakawa, H., Sekiguchi, M., & Cai, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.016 · Cited by 106
Regulation of claudins in blood-tissue barriers under physiological and pathological states
Gonçalves, A., Ambrósio, A. F., & Fernandes, R. (2013) · Tissue Barriers · doi:10.4161/tisb.24782 · Cited by 86
Viggars, A. P., Wharton, S. B., Simpson, J. E., Matthews, F. E., Brayne, C., Savva, G. M., Garwood, C., Drew, D., Shaw, P. J., & Ince, P. G. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.049 · Cited by 94
A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease
Singh, Y. P., Rai, H., Singh, G., Singh, G. K., Mishra, S. K., Kumar, S., Srikrishna, S., & Modi, G. P. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113278 · Cited by 100
Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease
Nunomura, A., Tamaoki, T., Tanaka, K., Motohashi, N., Nakamura, M., Hayashi, T., Yamaguchi, H., Shimohama, S., Lee, H.-G., Zhu, X., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.012 · Cited by 80
Self-citationAge-Dependent Accumulation of 8-Oxoguanine in the DNA and RNA in Various Rat Tissues
Nie, B., Gan, W., Shi, F., Hu, G.-X., Chen, L.-G., Hayakawa, H., Sekiguchi, M., & Cai, J.-P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/303181 · Cited by 83
The role of iron as a mediator of oxidative stress in Alzheimer disease
Castellani, R. J., Moreira, P. I., Perry, G., & Zhu, X. (2012) · BioFactors · doi:10.1002/biof.1010 · Cited by 81
Self-citationGarcia‐Esparcia, P., Llorens, F., Carmona, M., & Ferrer, I. (2014) · Brain Pathology · doi:10.1111/bpa.12137 · Cited by 80
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 86
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia
Jørgensen, A., Broedbaek, K., Fink‐Jensen, A., Knorr, U., Soendergaard, M. G., Henriksen, T., Weimann, A., Jepsen, P., Lykkesfeldt, J., Poulsen, H. E., et al. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.01.033 · Cited by 85
Fourcade, S., Ferrer, I., & Pujol, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.041 · Cited by 76
Cimini, A., Moreno, S., D'Amelio, M., Cristiano, L., D'Angelo, B., Falone, S., Benedetti, E., Carrara, P., Fanelli, F., Cecconi, F., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1199 · Cited by 68
Isobe, C., Abe, T., & Terayama, Y. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5333-x · Cited by 79
Potential application of the oxidative nucleic acid damage biomarkers in detection of diseases
Guo, C., Ding, P., Xie, C., Ye, C., Ye, M., Pan, C., Cao, X., Zhang, S., & Zheng, S. S. (2017) · Oncotarget · doi:10.18632/oncotarget.20801 · Cited by 76
Role of Oxidative RNA Damage in Chronic-Degenerative Diseases
Fimognari, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/358713 · Cited by 64
Jorgensen, A., Krogh, J., Miskowiak, K., Bolwig, T. G., Kessing, L. V., Fink-Jensen, A., Nordentoft, M., Henriksen, T., Weimann, A., Poulsen, H. E., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.011 · Cited by 74
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 75
Recent Advances: Molecular Mechanism of RNA Oxidation and Its Role in Various Diseases
Li, Z., Chen, X., Liu, Z., Ye, W., Li, L., Qian, L., Ding, H., Li, P., & Aung, L. H. H. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00184 · Cited by 73
Potential therapeutic use of plant flavonoids in AD and PD
Meng-zhen, S., Ju, L., Zhang, L., Cai-feng, D., Shu-da, Y., Hao-fei, Y., & Wei-yan, H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11440 · Cited by 61
Does ionizing radiation influence Alzheimer's disease risk?
Begum, N., Wang, B., Mori, M., & Varès, G. (2012) · Journal of Radiation Research · doi:10.1093/jrr/rrs036 · Cited by 59
Fourcade, S., López-Erauskin, J., Ruiz, M., Ferrer, I., & Pujol, A. (2014) · Biochimie · doi:10.1016/j.biochi.2013.09.012 · Cited by 55
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Diaz Brinton, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 49
Pogue, A. I., Jones, B. M., Bhattacharjee, S., Percy, M. E., Zhao, Y., & Lukiw, W. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089615 · Cited by 53
The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
Carvalho, C., Correia, S. C., Cardoso, S., Plácido, A. I., Candeias, E., Duarte, A. I., & Moreira, P. I. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1058160 · Cited by 54
Self-citationEnergy and the Alzheimer brain
Mamelak, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.001 · Cited by 54
Hofer, T., & Perry, G. L. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.06.005 · Cited by 52
Self-citationNunomura, A., Lee, H., Zhu, X., & Perry, G. L. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160433 · Cited by 50
Self-citationIncreased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan
Lin, C.-E., Chung, C.-H., Chen, L.-F., & Chi, M.-J. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.05.005 · Cited by 41
Gehlot, P., Kumar, S., Vyas, V. K., Choudhary, B. S., Sharma, M., & Malik, R. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117047 · Cited by 47
Long, J. M., & Lahiri, D. K. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.043 · Cited by 43
Oxidative Stress and Amyloid Toxicity: Insights From Yeast
França, M. B., Lima, K., & Eleuthério, E. C. A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25803 · Cited by 45
Role of RNA Oxidation in Neurodegenerative Diseases
Liu, Z., Chen, X., Li, Z., Ye, W., Ding, H., Li, P., & Aung, L. H. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145022 · Cited by 45
Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis
Hoffman, W. H., Siedlak, S. L., Wang, Y., Castellani, R. J., & Smith, M. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.085 · Cited by 44
Self-citationLocalized control of oxidized RNA
Zhan, Y., Dhaliwal, J. S., Adjibade, P., Uniacke, J., Mazrouï, R., & Zerges, W. (2015) · Journal of Cell Science · doi:10.1242/jcs.175232 · Cited by 41
Gupta, K., Chandran, S., & Hardingham, G. E. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12022 · Cited by 41
The role of RNA processing in the pathogenesis of motor neuron degeneration
Bäumer, D., Ansorge, O., Almeida, M., & Talbot, K. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001523 · Cited by 39
Neuroprotection through Stimulation of Mitochondrial Antioxidant Protein Expression
Greco, T., & Fiskum, G. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100519 · Cited by 34
Szczerba, M., Johnson, B. P., Acciai, F., Gogerty, C., McCaughan, M., Williams, J., Kibler, K. V., & Jacobs, B. L. (2023) · Science Signaling · doi:10.1126/scisignal.abq0837 · Cited by 39
Zhou, Y., Yao, Y., Shao, Y., Qu, W., Chen, Y., & Jiang, Q. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.07.089 · Cited by 38
Evolution of cubic membranes as antioxidant defence system
Deng, Y., & Almsherqi, Z. A. (2015) · Interface Focus · doi:10.1098/rsfs.2015.0012 · Cited by 36
Xu, Z., Huang, J., Gao, M., Guo, G., Zeng, S., Chen, X., Wang, X., Gong, Z., & Yan, Y. (2020) · GeroScience · doi:10.1007/s11357-020-00209-w · Cited by 35
Soontornniyomkij, V., Risbrough, V. B., Young, J. W., Wallace, C. K., Soontornniyomkij, B., Jeste, D. V., & Achim, C. L. (2010) · AGE · doi:10.1007/s11357-010-9145-9 · Cited by 34
Czarny, P. L., Białek, K. I., Ziółkowska, S., Strycharz, J., & Śliwiński, T. (2019) · Mutagenesis · doi:10.1093/mutage/gez035 · Cited by 34
The oligodeoxynucleotide probes for the site-specific modification of RNA
Sasaki, S., Onizuka, K., & Taniguchi, Y. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15066a · Cited by 33
Atamna, H. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9246-2 · Cited by 33
Dementia, stroke and migraine — Some common pathological mechanisms
Sas, K., Párdutz, Á., Toldi, J., & Vécsei, L. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.001 · Cited by 33
Vaccine Development to Treat Alzheimer’s Disease Neuropathology in APP/PS1 Transgenic Mice
Carrera, I., Etcheverría, I., Fernández‐Novoa, L., Lombardi, V., Cacabelos, R., & Vigo, C. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/376138 · Cited by 32
The Significance of 8-oxoGsn in Aging-Related Diseases
Zhang, X., & Li, L. (2020) · Aging and Disease · doi:10.14336/ad.2019.1021 · Cited by 28
Che, Y., Cui, Y., Tan, H. T., Andreazza, A. C., Young, L. T., & Wang, J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2993-0 · Cited by 25
Naked mole-rats resist the accumulation of hypoxia-induced oxidative damage
Hadj‐Moussa, H., Eaton, L., Cheng, H., Pamenter, M. E., & Storey, K. B. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111282 · Cited by 26
Redmayne, M., & Johansson, O. (2015) · Reviews on Environmental Health · doi:10.1515/reveh-2015-0030 · Cited by 25
Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson’s disease
Zhang, H., Liu, X., Liu, Y., Liu, J., Gong, X., Li, G., & Tang, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.975248 · Cited by 24
Papadakis, K. A., Doufexi, A., Kalamaki, M. S., Bourazanas, E., & Lymperaki, E. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15080384 · Cited by 23
DNA versus RNA oxidation in Parkinson’s disease: Which is more important?
Gmitterová, K., Gawinecka, J., Heinemann, U., Valkovič, P., & Zerr, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.048 · Cited by 23
Electromagnetic radiation and Alzheimer’s disease
Dasdag, O., Adalier, N., & Daşdağ, S. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1820378 · Cited by 22
Oxidatively generated DNA/RNA damage in psychological stress states.
Jørgensen, A. (2013) · PubMed · Cited by 22
Hosaka, T., Tsuji, H., & Tamaoka, A. (2021) · Processes · doi:10.3390/pr9091667 · Cited by 20
Oxidative Damage on RNA Nucleobases
Küpfer, P. A., & Leumann, C. J. (2014) · RNA technologies · doi:10.1007/978-3-642-54452-1_5 · Cited by 20
Pujol, A. (2015) · Endocrine development · doi:10.1159/000439340 · Cited by 20
Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain
Kharel, P., McDonough, J. A., & Basu, S. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.12.002 · Cited by 18
Release of redox enzymes and micro-RNAs in extracellular vesicles, during infection and inflammation
Caserta, S., & Ghezzi, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.010 · Cited by 18
Liu, J., Baum, L., Yu, S., Lin, Y., Xiong, G., Chang, R. C., So, K., & Chiu, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.788798 · Cited by 18
Jitsuzaki, D., Onizuka, K., Nishimoto, A., Oshiro, I., Taniguchi, Y., & Sasaki, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku538 · Cited by 17
Yang, S., Zhang, X., Sun, X.-S., Ling, T.-J., Feng, Y., Du, X., Zhao, M., Yang, Y., Xue, D., Wang, L., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100621 · Cited by 17
NAT8L mRNA oxidation is linked to neurodegeneration in multiple sclerosis
Kharel, P., Singhal, N. K., Mahendran, T., West, N. R., Croos, B., Rana, J., Smith, L. A., Freeman, E. J., Chattopadhyay, A., McDonough, J. A., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.02.007 · Cited by 16
Oshiro, I., Jitsuzaki, D., Onizuka, K., Nishimoto, A., Taniguchi, Y., & Sasaki, S. (2015) · ChemBioChem · doi:10.1002/cbic.201500084 · Cited by 16
Oxidative stress hypothesis for Alzheimer’s disease and its potential therapeutic implications
Nunomura, A. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.1043 · Cited by 16
Self-citationLukiw, W. J., Bjattacharjee, S., Zhao, Y., Pogue, A. I., & Percy, M. E. (2012) · PubMed · doi:10.4172/2161-0460.s2-0011 · Cited by 14
Kinoshita, K., Otsuka, R., Takada, M., Nishita, Y., Tange, C., Jinzu, H., Suzuki, K., Shimokata, H., Imaizumi, A., & Arai, H. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04359-2 · Cited by 12
Metadata
- Authors
- Nunomura, A., Hofer, T., Moreira, P. I., Castellani, R. J., Smith, M. A., & Perry, G.
- Affiliations
- University of Yamanashi (JP)
- University of Florida (US)
- Centro de Neurociências e Biologia Celular (PT)
- University of Maryland, Baltimore (US)
- Case Western Reserve University (US)
- The University of Texas at San Antonio (US)
- Corresponding author
- Nunomura, Akihiko
- Perry, George
- Venue
- Acta Neuropathologica
- Published
- 2009-03-07
- Volume
- 118
- Issue
- 1
- Pages
- 151-166
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2019628288
- Cited by
- 148
- References
- 138
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 7 · 2021: 5 · 2020: 11 · 2019: 6 · 2018: 2 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 7 · 2013: 13 · 2012: 22
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- RNA oxidation, oxidative RNA damage, Alzheimer's disease, neurodegenerative diseases, Parkinson's disease, dementia with Lewy bodies, amyotrophic lateral sclerosis, non-coding RNA, reactive oxygen species, mitochondrial oxidative stress, age-related neurodegeneration, gene expression regulation, pathogenesis
- MeSH terms
- Superoxide Dismutase-1, Aging, Alzheimer Disease, Animals, Brain, Hypoxia, Brain, Disease Models, Animal, DNA, Guanosine, Humans, Neurons, Oxidation-Reduction, RNA, Superoxide Dismutase, Reactive Oxygen Species, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.